WillItSurvive
Medical technology and health companies · China

United Imaging Healthcare

united-imaging.com ↗

Chinese maker of CT, MRI, and PET imaging systems competing globally with Siemens, GE, Philips.

Defensible for now
Assessed 30 July 2026 · Evidence as of 30 July 2026
Real protection, with named pressure against it.
On the recordSince 30 July 2026 · Checkable from 2026-08-20 · Every call on the record Checkpoint: Q2 2026 earnings release
The call

United Imaging keeps growing overseas and building its own AI tools, while its home market shrinks and US-China trade friction sits over its North America growth.

United Imaging Healthcare makes CT scanners, MRI machines, and ultrasound equipment sold in hospitals globally. It is hard to replace because doctors and hospitals get used to the machines, the company has cleared over 100 regulatory approvals, and its software updates tie customers to its platform, similar to how Siemens, GE, and Philips lock in their own customers. However, growth is slowing in China (its home market shrank 21 percent in early 2026), and the company sells heavily to North America, which now faces US restrictions on Chinese tech, meaning trade rules could cut off a major revenue source faster than the company can shift production to its new Texas factory. The one thing that could save the picture is if the US and China reach a trade deal that keeps United Imaging's American sales open, or if the Texas plant ramps up fast enough to sidestep the restrictions entirely.

Why
01
AI pressure: Pure-software AI diagnostic vendors (e.g. Aidoc, Viz.ai style reading-layer tools). Software-only AI readers could commoditize diagnosis, but United Imaging ships its own AI-enabled scanners instead of ceding that layer. Could AI do the core job? Unlikely.
02
Bigger players: Siemens Healthineers, GE HealthCare, Philips Healthcare. These three still hold roughly 90% of global imaging share and compete hard on price and service, even as United Imaging takes share from them. Could a giant copy it? Probably.
03
What protects it. 58 FDA clearances, 75 CE marks, 30,000+ installed systems, and a lifetime software-upgrade model that locks buyers in.
What would change this call
Q2 2026 earnings (due Aug 20, 2026) show revenue growth below or near +17.3% YoY. Deceleration is structural, not one quarter, weakening the growth story.
US North America revenue growth rate reported for Q2/Q3 2026 versus prior +56% YoY. Whether trade friction or procurement restrictions are biting UIH's key overseas offset.
Formal US entity-list action, procurement ban, or new tariff targeting UIH announced in 2026. Geopolitical risk has moved from watch-item to actual revenue impairment.
Key numbers
  • FY2025 revenue RMB 13.80B, up 33.98% YoY (2025-12-31)
  • Q1 2026 revenue growth slowed to +17.34% YoY (2026-03-31)
  • China domestic imaging market fell 21.1% YoY (2026-03-31)
Named risks
  • China domestic imaging market contracted 21.1% YoY in Q1 2026. Severity: high
  • China's June 22, 2026 export-control and procurement restrictions could hit US-facing revenue. Severity: high
  • Active US ITC investigation 337-TA-1483 in medical imaging devices category. Severity: medium
  • Revenue growth decelerating: 17.34% YoY in Q1 2026 vs historical ~20%+ rates. Severity: medium
Rivals, as read in July 2026
RivalDirectionEvidence
Siemens Healthineers, GE HealthCare, Philips HealthcarecontestingBig 5 incumbents hold ~90% global imaging share as of 2026-03-31, per gminsights.com
GE HealthCarecontestingGE holds ~32% North America imaging share (FY2024) while UIH's NA revenue grew 56% YoY in 2025
Chinese domestic incumbentsgaining onUIH ranked #1 for new China market share in comprehensive imaging (ex-ultrasound/DSA) in 2024
Pure-software AI diagnostic vendorscontestingUIH counters with 20+ FDA-cleared AI devices and Yuanzhi model as of 2025-12-31
Questions people ask
What is United Imaging's biggest risk?
The biggest risk is US trade policy, not commercial competition: a live Section 232 investigation into Chinese medical devices could restrict the roughly 24.9% of 2025 revenue, RMB 3.43 billion, that came from overseas markets (as of 2025-12-31). Possible addition to the US Entity List is a dated watch-item worth checking through the end of 2026, since it could affect growth in markets where United Imaging has been gaining fast against Western rivals.
Is United Imaging in financial trouble?
The numbers show no signs of financial trouble: FY2025 revenue reached RMB 13.80 billion with net profit of RMB 1.87 billion (as of 2025-12-31), and Q1 2026 revenue was RMB 2.91 billion. Growth did slow from 34% for full-year 2025 to about 17% year over year in Q1 2026, a trend worth re-checking at the H1 2026 earnings release due August 20, 2026.
Who are United Imaging's biggest competitors?
Its main competitors are Siemens Healthineers, GE HealthCare, Philips Healthcare and Canon Medical Systems, all established makers of CT, MRI and PET systems already shipping competing products worldwide. United Imaging is currently growing faster overseas than these four, with North America revenue up 56% and Europe up 50% year over year in 2025, per its FY2025 report (as of 2025-12-31).
Is United Imaging at risk from AI?
Not directly. Its AI threat status is rated 'not applicable' as of the July 2026 assessment, because AI mainly appears as a feature inside its scanners, such as faster image reconstruction and lower radiation dose, rather than as a separate product competing against its hardware sales.
How does United Imaging's moat compare to other medical device makers?
United Imaging's moat rests on its China manufacturing scale, cost position, and a growing base of certified products that are hard for rivals to replicate quickly. Per its FY2025 report and a CMB International analyst note dated 2026-04-28, North America revenue grew 56% year over year in 2025, Europe grew 50%, and APAC grew 41%, all faster than the pace being reported by Siemens Healthineers, GE HealthCare, Philips Healthcare and Canon Medical Systems. Siemens Healthineers has itself flagged structural pressure on its China diagnostics business, a sign United Imaging's domestic and export push is being felt.
What should I watch next for United Imaging?
Two dated checkpoints matter: whether United Imaging avoids addition to the US BIS Entity List through the end of 2026, and whether North America revenue growth stays above 20% year over year in the H1 2026 results due August 20, 2026. Q1 2026 revenue growth already slowed to around 17% year over year (as of 2026-03-31), so the August release will show whether that softening continues.
Timeline
  • 2026-07-20UIH Intelligence co-CEO says company avoiding 'extreme' internal AI rollout
  • 2026-06-22China adds export control and procurement restrictions on US entities
  • 2026-04-30United Imaging approves CNY 600 million share buyback
  • 2026-04-29FY2025 annual report and Q1 2026 results released
  • 2026-03-31Q1 2026 revenue up 17.34% YoY; China imaging market down 21.1% YoY
  • 2025-06-30United Imaging Intelligence raises ~RMB 1 billion Series A
  • 2025-01Pearland, TX manufacturing expansion announced
  • 2022-08IPO on Shanghai STAR Market, raising ~$1.6 billion
  • 2020-01Houston, TX regional HQ and manufacturing plant opened
  • 2011-03-21Company founded in Shanghai by Xue Min and Zhang Qiang
Head to head
GE HealthCare Technologies vs United Imaging Healthcare
Revision history
30 July 2026
First assessed. Defensible for now. The text above is fixed as of this date and is not edited afterwards.
In the same band
AbridgeSeegeneOlympus Corporation
More in Medical technology and health companies →
Sources